ORBUSNEICH (06929): Liu Guizhen has been appointed as Co-CEO.
Yueju Medical (06929) announced that Ms. Liu Guizhen, an executive director, has been appointed as the co-CEO of the company, sharing the position with Mr. Qian Yongxun; she will no longer serve as the company's Chief Operating Officer, effective from August 17, 2026.
ORBUSNEICH (06929) announced that Ms. Liu Guizhen, the executive director, has been appointed as the co-Chief Executive Officer of the company, sharing this position with Mr. Qian Yongxun; and she will no longer serve as the Chief Operating Officer, effective from August 17, 2026.
Mr. Chen Yongcheng, the executive director, has been appointed as the Chief Operating Officer of the company; and he will no longer serve as the Chief Financial Officer and Company Secretary, effective from August 17, 2026.
Ms. Chen Wenying has been appointed as the Chief Financial Officer and Company Secretary of the company, effective from August 17, 2026.
Related Articles
CHINA LILANG (01234) will distribute a special dividend of HKD 0.04 per share on September 23.
CHINA LILANG (01234) will distribute an interim dividend of HKD 0.1 per share on September 23.
CHINA LILANG (01234) released its interim results, with a profit attributable to shareholders of 215 million yuan, a year-on-year decrease of 11.2%.
CHINA LILANG (01234) will distribute a special dividend of HKD 0.04 per share on September 23.
CHINA LILANG (01234) will distribute an interim dividend of HKD 0.1 per share on September 23.
CHINA LILANG (01234) released its interim results, with a profit attributable to shareholders of 215 million yuan, a year-on-year decrease of 11.2%.
RECOMMEND
